How to buy Avinger stock | 0.269

Avinger, Inc is a medical devices business based in the US. Avinger shares (AVGR) are listed on the NASDAQ and all prices are listed in US Dollars. Avinger employs 74 staff and has a trailing 12-month revenue of around USD$8.7 million.

How to buy shares in Avinger

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Avinger. Find the stock by name or ticker symbol: AVGR. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Avinger reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$0.269, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Avinger, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Avinger. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Avinger's share price?

Since the stock market crash in March caused by coronavirus, Avinger's share price has had significant negative movement.

Its last market close was USD$0.269, which is 59.85% down on its pre-crash value of USD$0.67 and 15.24% down on the lowest point reached during the March crash when the shares fell as low as USD$0.31.

If you had bought USD$1,000 worth of Avinger shares at the start of February 2020, those shares would have been worth USD$613.76 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$430.40.

Avinger share price

Use our graph to track the performance of AVGR stocks over time.

Avinger shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	USD$0.269
52-week range	USD$0.2411 - USD$1.63
50-day moving average	USD$0.3484
200-day moving average	USD$0.3957
Wall St. target price	USD$1
PE ratio	0.0934
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-7.02

Buy Avinger shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Avinger stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Avinger, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Avinger price performance over time

Historical closes compared with the close of $0.269 from 2020-11-16

1 week (2020-11-20)	-8.81%
1 month (2020-10-30)	13.50%
3 months (2020-08-28)	-47.25%
6 months (2020-05-29)	-27.69%

1 year (2019-11-29)	-82.19%
2 years (2018-11-29)	-7.24%
3 years (2017-11-29)	3.50%
5 years (2015-11-27)	-98.49%

Is Avinger under- or over-valued?

Valuing Avinger stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avinger's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avinger's P/E ratio

Avinger's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Avinger shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Avinger financials

Revenue TTM	USD$8.7 million
Gross profit TTM	USD$2.9 million
Return on assets TTM	-40.5%
Return on equity TTM	-224.34%
Profit margin	-225.26%
Book value	$0.147
Market capitalisation	USD$26 million

TTM: trailing 12 months

Shorting Avinger shares

There are currently 539,509 Avinger shares held short by investors – that's known as Avinger's "short interest". This figure is 78.3% down from 2.5 million last month.

There are a few different ways that this level of interest in shorting Avinger shares can be evaluated.

Avinger's "short interest ratio" (SIR)

Avinger's "short interest ratio" (SIR) is the quantity of Avinger shares currently shorted divided by the average quantity of Avinger shares traded daily (recently around 10.8 million). Avinger's SIR currently stands at 0.05. In other words for every 100,000 Avinger shares traded daily on the market, roughly 50 shares are currently held short.

However Avinger's short interest can also be evaluated against the total number of Avinger shares, or, against the total number of tradable Avinger shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avinger's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Avinger shares in existence, roughly 10 shares are currently held short) or 0.0064% of the tradable shares (for every 100,000 tradable Avinger shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Avinger.

Find out more about how you can short Avinger stock.

Avinger share dividends

We're not expecting Avinger to pay a dividend over the next 12 months.

Have Avinger's shares ever split?

Avinger's shares were split on a 1:10 basis on 24 June 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avinger shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Avinger shares which in turn could have impacted Avinger's share price.

Avinger share price volatility

Over the last 12 months, Avinger's shares have ranged in value from as little as $0.2411 up to $1.63. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avinger's is 1.6768. This would suggest that Avinger's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Avinger overview

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.

Frequently asked questions

• What percentage of Avinger is owned by insiders or institutions?

  Currently 0.491% of Avinger shares are held by insiders and 13.349% by institutions.

• How many people work for Avinger?

  Latest data suggests 74 work at Avinger.

• When does the fiscal year end for Avinger?

  Avinger's fiscal year ends in December.

• Where is Avinger based?

  Avinger's address is: 400 Chesapeake Drive, Redwood City, CA, United States, 94063

• What is Avinger's ISIN number?

  Avinger's international securities identification number is: US0537341093

• What is Avinger's CUSIP number?

  Avinger's Committee on Uniform Securities Identification Procedures number is: 053734109